Viewing Study NCT05461794


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2026-02-24 @ 2:30 PM
Study NCT ID: NCT05461794
Status: TERMINATED
Last Update Posted: 2025-06-13
First Post: 2022-07-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma
Sponsor: BeiGene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None esophageal squamous cell carcinoma View